Portfolio company
Archean Sciences
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
Archean Sciences develops brain-on-a-chip systems using living human neurons to provide drug testing and energy-efficient computing for pharmaceutical and artificial intelligence firms.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Bexorg
Bexorg provides an AI-powered perfusion platform using post-mortem human brains to facilitate central nervous system drug discovery for pharmaceutical and academic researchers.
BrainZell
The company develops brain organoid models and computational tools for pharmaceutical firms to discover central nervous system drugs and test their efficacy.
Itay&Beyond
The company develops patient-derived brain organoids and an artificial intelligence platform for pharmaceutical firms to test drug efficacy for neurological and psychiatric disorders.
Frontier Computing
This company develops biological neural tissue hardware and cloud infrastructure for developers to train and run machine learning models on living neuronal substrates.
iOrganBio
This company develops an artificial intelligence-guided manufacturing platform to produce engineered human cells and organoids for biopharmaceutical researchers and clinical partners.
Oscillution
This company provides in vitro human brain cell models and testing platforms to pharmaceutical and biotech firms for drug discovery and safety assessment.
SpiNNcloud
This company produces neuromorphic supercomputing platforms and chips for research institutions, government agencies, and enterprises requiring energy-efficient artificial intelligence inference.
Neuronova
The company develops energy-efficient neuromorphic processors to enable edge artificial intelligence in battery-powered devices and sensors for manufacturers of wearables, medical equipment and electronics.
